Citi Reaffirms Buy Rating on Abbott (ABT) Following Favorable Court Ruling [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Citi Reaffirms Buy Rating on Abbott (ABT) Following Favorable Court Ruling Courtesy of Abbott Labs On October 24, Citi a?nalyst Joanne Wuensch reaffirmed a Buy rating on? Abbott Laboratories (NYSE:ABT), as reported by The Fly. She highlighted? t?h?at Judg?e Pallmeyer of? the US Distr?ict Court f?or the Nort?hern District of Illinois granted summary judgme?nt in Abbott's favor? in the thi?rd of four bellw?ether case?s related to the multi-district? litiga?tion ov?er cow's? milk-based infant fo?rmulas. Ci?ti views thi?s dismissal pos?iti?vely, noting it could set a precedent for eval?uating the re?maining N?EC? cases. Looking ahead t?o 2026, Abbott Laboratories (NYSE:ABT)'s management reiterated gu?idance for high sing?le-di?git organ?ic? s?ale?s growth? an?d dou?ble-?digit? EPS growth. Chairm?an? and CEO Robert Ford emphasized that the com?pany remains on track to achieve these? tar?get?s, suppo?rted by easing diagnostic headw?inds in China, reduced tariffs, stronger contributio
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Is Abbott Laboratories Fairly Priced After Growth In Devices And Diagnostics? [Yahoo! Finance]Yahoo! Finance
- Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement [Yahoo! Finance]Yahoo! Finance
- Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health MovementPR Newswire
- 7 deaths linked to faulty blood glucose monitors as FDA issues safety warning [FOX Business Network]FOX Business Network
- UBS Reaffirms Buy Rating on Abbott Laboratories (ABT) Amid Exact Sciences Acquisition [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 10/15/25 - In-Line
ABT
Sec Filings
- 12/3/25 - Form SCHEDULE
- 11/25/25 - Form 4
- 11/25/25 - Form 144
- ABT's page on the SEC website